Microfluidics technology for physiologically relevant assays
Jeff Jensen, CEO of Fluxion Biosciences describes how microfluidics technology fuels drug discovery through physiologically relevant cell-based models
Source: selectscience.net
Stay updated with breaking news from Modernization Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jeff Jensen, CEO of Fluxion Biosciences describes how microfluidics technology fuels drug discovery through physiologically relevant cell-based models
A number of lawsuits, ranging from particular components such as the mandate to purchase healthcare to the bill in its entirety, have challenged the constitutionality of the Patient Protection and Aff...
Posts about universal music written by Mike Masnick and Techdirt
Posts about great 78s written by Mike Masnick and Techdirt
Posts about matt oppenheim written by Mike Masnick